PCSK9 and metabolic syndrome: In pregnant women, PCSK9 levels were significantly higher in the gestational diabetes mellitus (GDM) group than those with standard glucose tolerance (NGT), suggesting a possible pathophysiological role for PCSK9 in GDM-related dyslipidemia and glycemic dysregulation.